The National Hemophilia Foundation (NHF) and Impact Education, LLC (IMPACT) have jointly announced the fourth annual National Hemophilia Foundation Annual Meeting pre-conference symposium has been specifically designed for pharmacists — including specialty, home health, health plan, and managed Medicaid pharmacists — as well as for medical directors and other healthcare professionals with an interest in hemophilia patient management.
CME/CPE-certified, the free event is set for July 21 from 1:45 p.m. to 5:00 p.m. EDT at the Gaylord Palms Resort & Convention Center in Orlando, Florida. It runs in conjunction with the NHF’s 68th Annual Meeting, themed “A Brighter Future Together,” which continues through July 23.
Hemophilia is an expensive-to-manage disorder, with total annual costs to patients or insurers that can reach $250,000 or more in severe cases. Optimal outcomes require a collaborative, coordinated approach that includes a hemophilia treatment center (HTC) and a specialty pharmacy, whose services can support patient treatment adherence and assist physicians, insurers and others in meeting clinical and financial goals.
The Orlando symposium will feature a multidisciplinary panel of experts, including a specialty pharmacist, a leading hematologist, a treatment center nurse coordinator, and a managed care pharmacy director. It consists of an advanced clinical update, and will emphasize the importance of well-coordinated treatment management with best practices designed to integrate hemophilia care with payer policies, and highlight the value of collaboration in implementing a hemophilia comprehensive care model.
The symposium is being jointly provided by NHF, IMPACT, and the Postgraduate Institute for Medicine, and is also in receipt of independent educational grants from Baxalta US Inc., Grifols, and Novo Nordisk, Inc.
Parties interested in attending the symposium can register at impactedu.net/specialtypharmacy16. Space is limited.
National Hemophilia Foundation (NHF)
Impact Education, LLC